Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin

被引:268
|
作者
Cavalli, R [1 ]
Gasco, MR
Chetoni, P
Burgalassi, S
Saettone, MF
机构
[1] Univ Turin, Dipartimento Sci & Tecnol & Farm, I-10125 Turin, Italy
[2] Univ Pisa, Dipartimento Chim Bioorgan & Biofarm, I-56126 Pisa, Italy
关键词
solid lipid nanoparticles; SLN; tobramycin; rabbits; preocular retention; ocular delivery; aqueous humour bioavailability;
D O I
10.1016/S0378-5173(02)00080-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim of this study was to evaluate solid lipid nanoparticles (SLN) as carriers for topical ocular delivery of tobramycin JOB). The SLN were in the colloidal size range (average diameter below 100 nm; polydispersity index below 0.2) and contained 2.5% TOB as ion-pair complex with hexadecyl phosphate. The preocular retention of SLN in rabbit eyes was tested using drug-free, fluorescent SLN (F-SLN): these were retained for longer times on the corneal surface and in the conjunctival sac when compared with an aqueous fluorescent solution. A suspension of TOB-loaded SLN (TOB-SLN) containing 0.3% w/v TOB was administered topically to rabbits, and the aqueous humour concentration of TOB was determined up to six hours. When compared with an equal dose of TOB administered by standard commercial eyedrops, TOB-SLN produced a significantly higher TOB bioavailability in the aqueous humour. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 50 条
  • [1] Solid lipid nanoparticles (SLN) for intravenous drug delivery
    Muller, RH
    zurMuhlen, A
    Freitas, C
    Mehnert, W
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 184 - 185
  • [2] Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery
    Shah, Kumar A.
    Date, Abhijit A.
    Joshi, Medha D.
    Patravale, Vandana B.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 345 (1-2) : 163 - 171
  • [3] Solid lipid nanoparticles for ocular drug delivery
    Seyfoddin, Ali
    Shaw, John
    Al-Kassas, Raida
    DRUG DELIVERY, 2010, 17 (07) : 467 - 489
  • [4] Factorial Design and Development of Solid Lipid Nanoparticles (SLN) for Gene Delivery
    Radaic, Allan
    de Paula, Eneida
    de Jesus, Marcelo Bispo
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2015, 15 (02) : 1793 - 1800
  • [5] SOLID LIPID NANOPARTICLES (SLN) - AN ALTERNATIVE COLLOIDAL CARRIER SYSTEM FOR CONTROLLED DRUG-DELIVERY
    MULLER, RH
    MEHNERT, W
    LUCKS, JS
    SCHWARZ, C
    ZURMUHLEN, A
    WEYHERS, H
    FREITAS, C
    RUHL, D
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1995, 41 (01) : 62 - 69
  • [6] Solid lipid nanoparticles (SLN) for controlled drug delivery -: a review of the state of the art
    Müller, RH
    Mäder, K
    Gohla, S
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) : 161 - 177
  • [7] Lipid Nanoparticles with a Solid Matrix (SLN, NLC, LDC) for Oral Drug Delivery
    Muchow, Marc
    Maincent, Philippe
    Mueller, Rainer H.
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2008, 34 (12) : 1394 - 1405
  • [8] Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)
    Fang, Jia-You
    Fang, Chia-Lang
    Liu, Chi-Hsien
    Su, Yu-Han
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (02) : 633 - 640
  • [9] Effective Delivery Routes and Strategies for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)
    Shastri, Divyesh H.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (43) : 6592 - 6601
  • [10] Incorporation of cyclosporin A in solid lipid nanoparticles (SLN)
    Ugazio, E
    Cavalli, R
    Gasco, MR
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 241 (02) : 341 - 344